BISTTRYOct 12, 18:19Live
AKCNS Price Target 2026Akçansa Çimento Sanayi ve Ticaret A.Ş.
- Volume
- TRY 100.3M
- Day range
- 211.10 – 223.50
- Previous close
- 221.40
- Market cap
- TRY 40.6B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The average price target of 8 brokers for AKCNS is TRY 292.37 (September 15, 2026), implying 37.91% from the last price.
Broker price targets, buy-hold-sell ratings and model portfolio status for Akçansa Çimento Sanayi ve Ticaret A.Ş. (AKCNS). The average target is compared with the current price to derive the implied upside; the AI fair value estimate is shown for comparison.
Last updated: Source: Broker research
Analyst Consensus
- Average target
- 292.37 TL
- Median target
- 303.50 TL
- Highest target
- 313.23 TL
- Lowest target
- 251.25 TL
- Upside
- 37.91%
- Buy / Hold / Sell
- 3 / 5 / 0
Broker Price Targets
| September 15, 2026 | Buy | 302.00 | 42.45% | |
| August 6, 2026 | Hold | 305.00 | 43.87% | |
| August 6, 2026 | Buy | 277.00 | 30.66% | |
| August 6, 2026 | Market perform | 308.00 | 45.28% | |
| August 6, 2026 | Buy | 308.50 | 45.52% | |
| August 6, 2026 | Market perform | 313.23 | 47.75% | |
| August 6, 2026 | Hold | 274.00 | 29.25% | |
| May 5, 2026 | Market perform | 251.25 | 18.51% | |
| December 24, 2025 | Outperform | 231.70 | — | |
| December 5, 2025 | Buy | 232.70 | — |
AI Fair Value
- AI fair value
- 239.78 TL
- Upside
- 13.10%
- Model date
- July 21, 2026
Frequently Asked Questions
How many brokers have a price target for AKCNS?
8 brokers have an average target of TRY 292.37 for AKCNS, with 3 buy, 5 hold and 0 sell ratings.
What are the highest and lowest price targets for AKCNS?
The highest price target for AKCNS is TRY 313.23, the lowest is TRY 251.25 and the median is TRY 303.50.
What is the AI price target for AKCNS?
Our AI fair value model estimates TRY 239.78 for AKCNS, a difference of 13.10% from the current price. The model was updated on July 21, 2026. Not investment advice.
Is a price target investment advice?
No. Price targets are opinions from broker research reports, provided for information only, not a recommendation to buy or sell.